Braxia Scientific Past Earnings Performance
Past criteria checks 0/6
Braxia Scientific has been growing earnings at an average annual rate of 28.4%, while the Healthcare industry saw earnings growing at 16.2% annually. Revenues have been growing at an average rate of 26.6% per year.
Key information
28.4%
Earnings growth rate
200.7%
EPS growth rate
| Healthcare Industry Growth | -6.7% |
| Revenue growth rate | 26.6% |
| Return on equity | n/a |
| Net Margin | -436.4% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Braxia Scientific makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 2 | -10 | 4 | 0 |
| 30 Sep 23 | 2 | -11 | 5 | 0 |
| 30 Jun 23 | 2 | -13 | 6 | 0 |
| 31 Mar 23 | 2 | -13 | 7 | 0 |
| 31 Dec 22 | 2 | -12 | 6 | 0 |
| 30 Sep 22 | 2 | -13 | 7 | 0 |
| 30 Jun 22 | 1 | -12 | 7 | 0 |
| 31 Mar 22 | 1 | -12 | 7 | 0 |
| 31 Dec 21 | 1 | -8 | 7 | 1 |
| 30 Sep 21 | 1 | -7 | 6 | 1 |
| 30 Jun 21 | 1 | -7 | 5 | 2 |
| 31 Mar 21 | 1 | -88 | 9 | 2 |
Quality Earnings: BRAX is currently unprofitable.
Growing Profit Margin: BRAX is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BRAX is unprofitable, but has reduced losses over the past 5 years at a rate of 28.4% per year.
Accelerating Growth: Unable to compare BRAX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: BRAX is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (15.3%).
Return on Equity
High ROE: BRAX's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.